GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Gross Profit

Simulations Plus (Simulations Plus) Gross Profit

: $48.59 Mil (TTM As of Feb. 2024)
View and export this data going back to 1997. Start your Free Trial

Simulations Plus's gross profit for the three months ended in Feb. 2024 was $13.22 Mil. Simulations Plus's gross profit for the trailing twelve months (TTM) ended in Feb. 2024 was $48.59 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Simulations Plus's gross profit for the three months ended in Feb. 2024 was $13.22 Mil. Simulations Plus's Revenue for the three months ended in Feb. 2024 was $18.31 Mil. Therefore, Simulations Plus's Gross Margin % for the quarter that ended in Feb. 2024 was 72.23%.

Simulations Plus had a gross margin of 72.23% for the quarter that ended in Feb. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Simulations Plus was 85.79%. The lowest was 73.05%. And the median was 76.49%.


Simulations Plus Gross Profit Historical Data

The historical data trend for Simulations Plus's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Gross Profit
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.94 30.94 35.87 43.08 47.95

Simulations Plus Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.13 13.27 12.25 9.85 13.22

Competitive Comparison

For the Health Information Services subindustry, Simulations Plus's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus Gross Profit Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Gross Profit distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Gross Profit falls into.



Simulations Plus Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Simulations Plus's Gross Profit for the fiscal year that ended in Aug. 2023 is calculated as

Gross Profit (A: Aug. 2023 )=Revenue - Cost of Goods Sold
=59.577 - 11.63
=47.95

Simulations Plus's Gross Profit for the quarter that ended in Feb. 2024 is calculated as

Gross Profit (Q: Feb. 2024 )=Revenue - Cost of Goods Sold
=18.305 - 5.084
=13.22

Gross Profit for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $48.59 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Simulations Plus's Gross Margin % for the quarter that ended in Feb. 2024 is calculated as

Gross Margin % (Q: Feb. 2024 )=Gross Profit (Q: Feb. 2024 ) / Revenue (Q: Feb. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=13.22 / 18.305
=72.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Simulations Plus  (NAS:SLP) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Simulations Plus had a gross margin of 72.23% for the quarter that ended in Feb. 2024 => Durable competitive advantage


Simulations Plus Gross Profit Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus (Simulations Plus) Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
Executives
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221